Drawing for EZ-TRACK

USPTO serial 79351133

EZ-TRACK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EZ-TRACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific diagnostic use; chemical laboratory preparations for scientific use; diagnostic preparations for scientific use, namely, diagnostic reagents and assays; diagnostic reagents for in-vitro use for biochemistry, clinical chemistry and microbiology; laboratory reagents for scientific use; universal reagents for automated laboratory testing systems; diagnostic testing materials other than for medical use; diagnostic biomarkers for analytical, research and scientific use; in-vivo diagnostic testing agents for scientific useACTIVE—
005Chemical preparations for medical use for blood analysis; in-vitro diagnostic preparations for medical use; analytical reagents for medical use; chemical diagnostic reagents for medical use; diagnostic biomarking reagents for medical use; reagents and substances for medical and veterinary diagnostic purposes; immunological reagents for medical use; reagents for in vitro laboratory use for medical use; diagnostic substances for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents for medical use sold as kits; diagnostic preparations for the evaluation of genomic analysis for medical use; diagnostic preparations for analyzing the presence of medicines in the blood; diagnostic preparations for analyzing the presence of anti-medication anti-bodies in the bloodACTIVE—
010Medical diagnostic instrument in the nature of automated analyzers for body fluids for medical use; medical diagnostic testing apparatus for immunoassay procedures; apparatus for analyzing the presence of medicines in the blood; apparatus for analyzing the presence of anti-medication anti-bodies in the blood; blood testing apparatus for medical use; testing instruments for use in medical diagnosis; electrical instruments for medical use for blood diagnosis; medical diagnostic-test instruments for immunoassay procedures; all the aforesaid excluding stretchers, emergency apparatus supports, back boards, carts and seats, all being for medical or surgical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 7, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 30, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 8, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 8, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 11, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 25, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 16, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 6, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 6, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 7, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 7, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 7, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 17, 2023RFNTREFUSAL PROCESSED BY IB—
Apr 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 25, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 3, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2023DOCKASSIGNED TO EXAMINER—
Nov 12, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 4, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 30, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 29, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance